In the report by Ye et al, MEK/ERK and PI3K/AKT pathways are often activated in CRC, and they cooperate to regulate survivin expression that is associated with metastatic progression and poor survival of CRC (60). Here, MAP2K7 is linked to colorectal carcinoma.